Ignite Creation Date:
2024-05-05 @ 4:35 PM
Last Modification Date:
2024-10-26 @ 9:22 AM
Study NCT ID:
NCT00273403
Status:
UNKNOWN
Last Update Posted:
2006-09-22
First Post:
2006-01-04
Brief Title:
Outcome Evaluation of Minority AIDS Initiative Programs in the New York EMA
Sponsor:
The New York Academy of Medicine
Organization:
The New York Academy of Medicine
Study Overview
Official Title:
Outcome Evaluation of Minority AIDS Initiative Programs in the New York EMA
Status:
UNKNOWN
Status Verified Date:
2006-09
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This outcome evaluation effort provides the opportunity to learn what programmatic approaches effectively address two of the most difficult hurdles in HIV health services delivery 1 getting people who would benefit from health care to use it and 2 getting people who do use health care to do so more consistently and effectively The New York HIV Planning Council through MHRA has funded 23 agencies to achieve these objectives for people of color with HIV disease
Detailed Description:
All clients are assessed upon entry into the program have their service utilization tracked and then are reassessed at three six and twelve months following program entry
The main client-level data elements collected during baseline and follow-up interviews are the following
Biological markers including HIV status viral load t-cell count
Demographic characteristics
Adherence to treatment
Barriers to care
Social support
Substance use and treatment
Functional health status
Functional Health Status is used in this evaluation as the primary measure of final client outcomes The Functional Health Status items we use are from the ACTG SF-21 a modified version of the Medical Outcomes Study instrument
The overall evaluation objectives are to
Describe the change in functional health status for different populations and groups of clients
Identify services or constellations of services and intensity of services associated with change in functional health status
Assess whether programs meet intermediate objectives decreased drug use increased service use improved housing stability
Identify barriers to access to and maintenance in care
The main client-level data elements collected during baseline and follow-up interviews are the following
Biological markers including HIV status viral load t-cell count
Demographic characteristics
Adherence to treatment
Barriers to care
Social support
Substance use and treatment
Functional health status
Functional Health Status is used in this evaluation as the primary measure of final client outcomes The Functional Health Status items we use are from the ACTG SF-21 a modified version of the Medical Outcomes Study instrument
The overall evaluation objectives are to
Describe the change in functional health status for different populations and groups of clients
Identify services or constellations of services and intensity of services associated with change in functional health status
Assess whether programs meet intermediate objectives decreased drug use increased service use improved housing stability
Identify barriers to access to and maintenance in care
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None